THE CHEMOURS COMPANY

(CC)
  Report
Delayed Nyse  -  04:00 2022-06-30 pm EDT
32.02 USD   +0.95%
06/14BofA Securities Downgrades Chemours to Neutral From Buy, Adjusts Price Target to $44 From $48
MT
06/09INSIDER SELL : Chemours
MT
06/06Alembic Global Adjusts Chemours Company Price Target to $51 From $40, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

The Chemours Company Announces Date for Thermal & Specialized Solutions Investor Webinar

04/12/2022 | 04:31pm EDT

The May 16 event will highlight the secular dynamics underpinning the decade of growth ahead

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced that it will host an investor webinar on May 16, 2022, at 10 a.m. Eastern Daylight Time. The event will focus on the Thermal & Specialized Solutions segment highlighting secular dynamics, key business drivers, and strategic initiatives for growth. Presenters will include Mark Newman, President and Chief Executive Officer, Alisha Bellezza, President Thermal & Specialized Solutions, and Jonathan Lock, SVP and Chief Development Officer.

The event is open to the public and can be accessed via live webcast through the Chemours Investor Relations website, or via this link.

This event will also be accessible by teleconference by dialing 833-502-0453; conference ID: 2376625 (inside the U.S.) or +1-778-560-2539; conference ID: 2376625 (outside the U.S.).

A webcast replay will be available following the presentation via this link.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration, and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products include prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™, Viton™, Nafion™, and Krytox™. The company has approximately 6,400 employees and 29 manufacturing sites serving approximately 3,200 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the current COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is still being determined and to date has included significant volatility in financial and commodity markets and a severe disruption in economic activity. The public and private sector response has led to travel restrictions, temporary business closures, quarantines, stock market volatility, and interruptions in consumer and commercial activity globally. Matters outside our control have affected our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2021. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.


© Business Wire 2022
All news about THE CHEMOURS COMPANY
06/14BofA Securities Downgrades Chemours to Neutral From Buy, Adjusts Price Target to $44 Fr..
MT
06/09INSIDER SELL : Chemours
MT
06/06Alembic Global Adjusts Chemours Company Price Target to $51 From $40, Maintains Overwei..
MT
05/27Chemours Considers Capacity Investments to Support Hydrogen Economy
MT
05/27Chemours Explores Capacity Investments to Advance Support of the Hydrogen Economy
BU
05/27The Chemours Company Explores Capacity Investments to Advance Support of the Hydrogen E..
CI
05/23Chemours Announces Process Innovation with New Viton™ Fluoroelastomers Advanced P..
BU
05/23The Chemours Company Announces Process Innovation with New Viton™ Fluoroelastomers..
CI
05/17Chemours Leads Remove2Reclaim Project to Advance Plastic Circularity
BU
05/16TRANSCRIPT : The Chemours Company - Special Call
CI
More news
Analyst Recommendations on THE CHEMOURS COMPANY
More recommendations
Financials (USD)
Sales 2022 7 085 M - -
Net income 2022 860 M - -
Net Debt 2022 2 343 M - -
P/E ratio 2022 6,08x
Yield 2022 3,15%
Capitalization 4 978 M 4 978 M -
EV / Sales 2022 1,03x
EV / Sales 2023 0,94x
Nbr of Employees 6 400
Free-Float 78,9%
Chart THE CHEMOURS COMPANY
Duration : Period :
The Chemours Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE CHEMOURS COMPANY
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 32,02 $
Average target price 45,36 $
Spread / Average Target 41,7%
EPS Revisions
Managers and Directors
Mark E. Newman President, Chief Executive Officer & Director
Sameer Ralhan Chief Financial Officer & Senior Vice President
Dawn L. Farrell Chairman
Randal King VP-Technology
Curtis V. Anastasio Independent Director
Sector and Competitors